| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.35 | 2e-09 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.29 | 1e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.33 | 5e-06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.29 | 3e-05 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-05 |